Expert consensus: Time for a change in the way we advise our patients to use topical corticosteroids

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 917-920

  Bewley, A ^a  

^a WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Corticosteroids; Finger tip unit; Potency; Sparingly; Topical

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; CORTICOSTEROID; DESOXIMETASONE; FLUTICASONE PROPIONATE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; PIMECROLIMUS; TRIAMCINOLONE ACETONIDE;

ADRENAL SUPPRESSION; ATOPIC DERMATITIS; BODY REGIONS; CONFERENCE PAPER; CONSENSUS; CORTICOSTEROID THERAPY; DOSE CALCULATION; DRUG EFFICACY; DRUG INFORMATION; DRUG LABELING; DRUG POTENCY; DRUG SAFETY; DRUG TREATMENT FAILURE; FINGER; FINGERTIP UNIT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PATIENT COUNSELING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; RECOMMENDED DRUG DOSE; SIDE EFFECT; SKIN ATROPHY; SKIN DISEASE; STRIA; TREATMENT DURATION; UNITED KINGDOM;

ADMINISTRATION, TOPICAL; DRUG LABELING; EVIDENCE-BASED MEDICINE; GLUCOCORTICOIDS; HUMANS; PRACTICE GUIDELINES AS TOPIC; SKIN DISEASES;

EID: 42049108012     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08479.x     Document Type: Conference Paper

References (14)

1. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary 52. Section 13.4: Topical corticosteroids. London : BMJ Publishing Group/RPS Publishing, 2006.
2. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000 141 : 931 6.
3. Long CC, Finlay AY. The finger-tip unit - a new practical measure. Clin Exp Dermatol 1991 16 : 444 7.
4. Patient UK. Fingertip Units for Topical Steroids. 2004. Available at: http://www.patient.co.uk (last accessed 4 December 2007).
5. Clement M. Treatment failure in dermatology. Dermatol Pract 1994 July/August : 7 9.
6. Beattie PE, Lewis-Jones MS. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol 2003 28 : 549 53.
7. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000 4 : 1 191.
8. van der Meer JB, Glazenburg EJ, Mulder PGH et al. The management of moderate to severe atopic eczema in adults with topical fluticasone propionate. Br J Dermatol 1999 140 : 1114 21.
9. Hanifin J, Gupta AK, Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol 2002 147 : 528 37.
10. Thomas KS, Armstrong S, Avery A et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 2002 324 : 1 7.
11. Luger TA, Lahfa M, Folster-Holst R et al. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis. J Dermatol Treat 2004 15 : 169 78.
12. Ellison JA, Patel L, Ray DW et al. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics 2000 105 : 794 9.
13. Cornell RC, Stoughton RB. Six month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis. Br J Dermatol 1981 105 : 91 5.
14. Katz HI, Hien NT, Prawer SE et al. Superpotent topical steroid treatment of psoriasis vulgaris - clinical efficacy and adrenal function. J Am Acad Dermatol 1987 16 : 804 11.